Vyvanse (lisdexamfetamine) is working when you notice a meaningful reduction in the core symptoms it was prescribed for, whether that is difficulty sustaining attention, impulsive behavior, or binge eating episodes. The change is not always dramatic or immediately obvious, because Vyvanse is a prodrug that your body converts gradually into its active form, with peak blood levels of d-amphetamine arriving around three hours after you take it. Knowing what to look for, and what not to confuse with a genuine response, makes a real difference in whether you and your prescriber land on the right dose.
What Happens After You Swallow the Capsule
Vyvanse is not an active stimulant when it enters your stomach. It is lisdexamfetamine, an inactive molecule that your body has to break apart before it does anything. After absorption, red blood cells cleave the lysine amino acid off the molecule, releasing d-amphetamine into your bloodstream. This conversion happens inside the red blood cell itself, driven by enzymes in the cell’s interior fluid rather than in the liver or gut wall.
In a pharmacokinetic study of healthy adults, intact lisdexamfetamine reached peak plasma levels about one hour after dosing and was eliminated rapidly, with a half-life of roughly half an hour. The active d-amphetamine, by contrast, peaked at about three hours and lingered much longer.
This built-in delay matters for what you should expect. You are unlikely to feel a sudden “kick” the way someone might with an immediate-release stimulant. Instead, the onset is gradual, and symptom control in classroom and workplace studies has been shown to last at least twelve hours.
Early Signs the Medication Is Doing Its Job
The clearest signal is a reduction in the specific symptoms that led to your diagnosis. For ADHD, that typically means you can sustain focus on a task without your mind wandering as often, you interrupt people less, or you find it easier to sit through a meeting without fidgeting. For binge eating disorder, the marker is fewer binge episodes per week. These changes can start within the first week of reaching a therapeutic dose, though the full picture often takes longer to emerge.
A meta-analysis pooling data from multiple randomized trials found that Vyvanse produced a large effect on ADHD symptom scales in both adults and children compared to placebo. The improvement was seen on both the inattention and hyperactivity-impulsivity dimensions, meaning the medication does not selectively fix one cluster of symptoms while ignoring the other. In adults, the effect sizes for each subscale were comparably large.
Beyond the core symptoms, many people notice improvements in what researchers call executive function: planning, organizing, starting tasks, and managing time. A post hoc analysis of adults with ADHD and executive function deficits found that Vyvanse improved self-reported executive functioning alongside standard ADHD symptom scores, and the two types of improvement tracked together. In practical terms, if you find yourself actually following through on a to-do list, remembering appointments without five alarms, or finishing a project you would normally abandon midway, those are signs the medication is reaching the right processes in your brain.
What “Working” Does Not Look Like
A common misconception is that a stimulant medication should make you feel euphoric, supercharged, or dramatically different. If that is what you are experiencing, the dose may actually be too high. A well-calibrated dose of Vyvanse should feel relatively subtle. You might not notice it working in the moment so much as you notice, looking back at your day, that things went more smoothly than usual.
Another misleading signal is hyperfocus on the wrong things. Stimulants can increase your ability to lock onto a task, but they do not choose which task. Spending four unbroken hours reorganizing a desk drawer or scrolling social media is not a sign of therapeutic success. The medication is working when your improved focus lands on the things you actually intended to do, which usually requires behavioral strategies alongside the prescription.
It is also worth knowing that Vyvanse can make some people feel calmer and quieter inside their own heads. This can be surprising if you expected a stimulant to feel stimulating. For people whose baseline mental state involves constant internal noise, racing thoughts, or restlessness, a reduction in that chaos is the therapeutic effect. If you feel oddly “flat” or emotionally blunted, though, that is a side effect worth discussing with your prescriber, not a sign the drug is doing what it should.
Tracking Your Response Over Time
Relying on gut feeling alone is unreliable because humans are bad at remembering how they felt two weeks ago. Structured tracking makes a real difference. Research on medication monitoring in ADHD has shown that standardized rating scales and performance-based tests both capture reductions in symptoms between baseline and one month, and between baseline and twelve months. You do not need fancy software to replicate this principle at home.
A simple approach is to rate yourself each evening on three or four concrete dimensions that matter to you. These might include:
- Task completion: How many of the things you planned to do actually got done?
- Impulsivity: Did you say or buy things you later regretted?
- Emotional regulation: How reactive were you to frustrations or interruptions?
- Time awareness: Did you lose track of time less often than usual?
Rating these on a simple one-to-five scale each day gives you and your prescriber something concrete to discuss at follow-up visits rather than a vague “I think it’s helping, maybe.” A week of daily ratings is far more informative than a single office visit impression. If you are being treated for binge eating disorder rather than ADHD, tracking the number of binge episodes per week and the intensity of urges serves the same purpose.
The Dose-Response Question
Vyvanse comes in doses ranging from 10 mg to 70 mg, and finding the right one is not as simple as “more drug equals more benefit.” An exploratory dose-response study in adults with ADHD found that higher Vyvanse doses were a significant predictor of lower symptom scores at the end of treatment, but the relationship was not one-size-fits-all. Baseline symptom severity was actually a stronger predictor of where someone ended up than the dose itself. In that study, about 95 percent of participants successfully reached their assigned dose, suggesting that most people tolerate the titration process well.
What this means practically is that if 30 mg feels like it is doing nothing, 50 mg might be your sweet spot, but if 50 mg is producing uncomfortable side effects with marginal symptom relief, going to 70 mg is unlikely to solve the problem. Your prescriber will typically start at 30 mg and increase in 10 or 20 mg increments every week or two, watching for the point where symptom improvement plateaus or side effects become a limiting factor. The goal is the lowest dose that gives you a meaningful functional improvement, not the highest dose you can tolerate.
Appetite, Weight, and the First Few Weeks
Decreased appetite is one of the most common early effects and often gets mistaken for a sign that the medication is “too strong.” A two-year open-label study in children and adolescents found that decreased appetite was typically first reported about two weeks into treatment, with weight decrease following about a month in. The appetite suppression tended to peak early and then decline over time, suggesting that your body partially adjusts.
If you are an adult, you may notice that you simply forget to eat, or that food seems less appealing during the hours when the medication is most active. This is a pharmacological side effect, not a therapeutic signal. Skipping meals can worsen afternoon crashes, increase irritability, and mimic the very concentration problems you are trying to treat. Eating a solid breakfast before or shortly after taking the dose, and setting a reminder to eat lunch even if you are not hungry, are practical strategies that most experienced prescribers recommend.
What About Sleep
Given that Vyvanse is a stimulant with a long duration of action, you might worry about insomnia. A controlled study in adults with ADHD looked specifically at this question using validated sleep-quality measures. Compared with placebo, Vyvanse did not significantly worsen global sleep quality, did not meaningfully increase the time it took to fall asleep, and did not shorten sleep duration. The baseline sleep onset latency in the study was about 25 to 30 minutes across groups, and Vyvanse did not push that number higher.
That said, individual experiences vary. Some people do find that taking Vyvanse too late in the morning shifts their alertness window into the evening. The standard advice is to take the dose first thing in the morning. If you are consistently lying awake past your usual bedtime and your dose timing is already early, that is useful information for your prescriber, but the controlled data suggest that sleep disruption is not an inevitable consequence of the medication.
Why Vyvanse’s Metabolism Makes It Unusual
One reason Vyvanse tends to produce a smoother experience than some other stimulants is its metabolic pathway. Unlike mixed amphetamine salts extended-release, which use a physical bead delivery system and are metabolized partly through a liver enzyme called CYP 2D6, Vyvanse bypasses the cytochrome P450 system entirely. Its conversion to d-amphetamine happens in red blood cells via aminopeptidase enzymes in the cell’s interior fluid.
This has a practical implication: your response to Vyvanse is less likely to be affected by other medications that interact with liver enzymes, and less likely to vary based on your individual CYP 2D6 genotype. Some people are rapid metabolizers or poor metabolizers of drugs processed by CYP 2D6, which can make other stimulant formulations unpredictable. Vyvanse sidesteps that variable. It does not mean the drug works identically in everyone, but it removes one common source of person-to-person variability.
Tolerance and the Question of Fading Effects
A worry many people have, sometimes within weeks of starting, is whether the medication is already losing its punch. A literature review on stimulant tolerance found widely varying numbers depending on how tolerance was defined and how long patients were followed. One clinical study reported that roughly a quarter of patients developed tolerance in a timeframe of days to weeks, while another found only about 3 percent developed tolerance over ten years. Long-term follow-up studies generally suggest that medication response can lessen over extended treatment durations for a meaningful percentage of patients.
The tricky part is distinguishing true pharmacological tolerance from other explanations. If the medication seemed to work brilliantly in your first week and now feels weaker, consider whether your initial impression was partly a novelty or placebo effect. The contrast between untreated and treated states is sharpest on day one. After a few weeks, the treated state becomes your new normal, and the improvement feels less dramatic even if your objective performance has not changed. This is where that daily tracking habit becomes invaluable: if your ratings are still better than baseline, the medication is still working even if the subjective “wow” has faded.
Genuine tolerance, where the same dose truly produces less symptom control over time, does happen. When it does, the typical response is a modest dose increase, though your prescriber may also evaluate whether life circumstances, sleep quality, or stress levels have changed enough to explain the shift before adjusting the medication.
How to Know It Is Not Working
If you have been on a stable dose for three to four weeks and see no improvement in the symptoms that led to treatment, the medication is probably not working at that dose. Signs of non-response include unchanged difficulty initiating tasks, the same frequency of careless mistakes, no reduction in impulsive decisions, or, for binge eating disorder, no meaningful drop in binge frequency.
Side effects without benefits are a particularly clear signal. If you are experiencing appetite suppression, dry mouth, or increased heart rate but none of the cognitive or behavioral improvements, the cost-benefit equation is unfavorable. Your prescriber may try a higher dose before concluding that Vyvanse is not the right medication, but there is a ceiling. If 70 mg, the maximum approved dose, produces side effects without adequate symptom relief, switching to a different medication class is usually the next step.
It is also worth noting that Vyvanse is not a fix for everything that might look like ADHD. Sleep deprivation, thyroid dysfunction, anxiety disorders, and depression can all produce concentration difficulties and restlessness. If a stimulant is not helping, one possibility is that the underlying problem was never a dopamine deficit in the first place. A thoughtful prescriber will revisit the diagnosis rather than simply escalating the dose indefinitely.
When Vyvanse Is Prescribed for Binge Eating Disorder
Vyvanse is the only stimulant medication with regulatory approval for moderate to severe binge eating disorder in adults, and the markers of success look different from ADHD treatment. The primary outcome in the pivotal trials was the number of binge eating days per week. Two twelve-week phase III trials showed that Vyvanse at 50 to 70 mg per day significantly reduced binge days compared to placebo, and a longer-term study with a withdrawal phase found that staying on the medication markedly reduced the risk of relapse. Subgroup analyses showed that the benefits held across gender and age groups.
If you are taking Vyvanse for binge eating, the question “is it working” comes down to whether your binge frequency and the intensity of binge urges are declining. Some reduction in the preoccupation with food and the feeling of loss of control during eating episodes is what you are looking for. Weight loss may or may not occur and is not the treatment target. If your binge episodes are dropping but your weight is unchanged, the medication is still doing its job. If binge episodes persist at the same frequency after adequate titration, the medication is not addressing the problem.
The Role of Other People’s Observations
One of the more underappreciated ways to gauge whether Vyvanse is working is to ask someone who sees you regularly. Research on ADHD rating scales has found that different informants can have different frames of reference when evaluating symptoms: parents and teachers, for example, do not always rate the same child identically. The same principle applies to adults. Your partner, a close coworker, or a friend who spends significant time with you may notice behavioral changes, like less interrupting, better follow-through on commitments, or fewer emotional outbursts, that you cannot see from the inside.
This is not about outsourcing your medical decisions. It is about recognizing that ADHD symptoms are often more visible to others than to the person experiencing them. If three people in your life independently comment that you seem more organized or less scattered, that is data. If nobody notices anything different and you are not sure either, that is also data. Combining your own self-ratings with informal feedback from people around you gives you a fuller picture than either source alone.
Interactions with Caffeine and Acidic Foods
A question that comes up constantly in online ADHD communities is whether coffee or acidic drinks interfere with Vyvanse. Because Vyvanse is a prodrug that gets converted in red blood cells rather than absorbed and activated in the gut in the same way as other stimulants, its pharmacokinetic profile is notably consistent. The carrier-mediated absorption of intact lisdexamfetamine, likely through the high-capacity PEPT1 transporter, and subsequent conversion in a high-capacity system in blood may contribute to this reproducible profile.
That said, caffeine is itself a stimulant, and stacking it on top of an amphetamine can amplify cardiovascular side effects like increased heart rate and elevated blood pressure. If you were a heavy coffee drinker before starting Vyvanse, you may need to reduce your intake, not because caffeine blocks the medication but because the combination can feel physically uncomfortable. Many people find they need less caffeine once their ADHD is treated, since the caffeine was partly self-medication for inattention in the first place.